Aurora Spine Corporation : First Surgical Implant of ZIP ULTRA(TM) MIS Interspinous Device Performed in Switzerland

Carlsbad California February 9 2015/Marketwired/ – Aurora Spine Corporation (TSXV: ASG) announced today the first surgical implant of the company’s ZIP ULTRA(TM) minimally invasive interspinous device in Switzerland.This surgery is part of Aurora Spine’s continuing efforts to expand the use of our ZIP MIS Fusion System in Europe. The surgery was performed at the Clinique Générale-Beaulieu in Geneva by Prof. Aymen Ramadan.

“The ZIP ULTRA MIS Fusion System is very easy to use” said Prof. Ramadan. “The instrumentation is very intuitive and the implantation is fast and simple via a small incision. It allows me to perform a short and safe surgery while minimizing the risk of nerve damage. The patient left the hospital pain free and is doing very well”.

“We are very excited to now offer our ZIP MIS product portfolio in Switzerland” said Sven Claes International Product Director of Aurora Spine. “We believe that our ZIP ULTRA MIS Fusion System is a true minimally invasive fusion system allowing the surgeon to perform a Screwless Procedure(TM). It is designed to be simple safe and secure and we are convinced it will improve patient outcomes in Switzerland as well as globally”.

Aurora Spine’s ZIP ULTRA MIS interspinous fixation implant for spinal fusion consists of the ONE-STEP(TM) locking mechanism which eliminates the use of a set screw articulating spikes and various sizes to accommodate variations in patient anatomy.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative minimally invasive regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties most of which are beyond the control of Aurora Spine including without limitation those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express or involve discussions as to expectations beliefs plans objectives assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and accordingly prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information please contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Eric Fronk
Chief Financial Officer
(760) 424-2004

www.aurora-spine.com

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content accuracy and originality of the information contained therein.

Source: Aurora Spine Corporation via GlobeNewswire
HUG#1892673
GlobeNewswire
http://inpublic.globenewswire.com/

More:  http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=107825#.VNuJj0Kpr8v#ixzz3RScz7yQY